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The aim of the study was to compare electrophysiological parameters of night sleep in narcolepsy type 1 and hypersomnia associated 
with a psychiatric disorder. Forty-four patients: 15 with narcolepsy type 1, 14 with hypersomnia associated with a psychiatric disorder 
and 15 age- and sex-matched controls participated in the study. The study subjects filled in the Athens Insomnia Scale (AIS) and the 
Beck Depression Inventory (BDI). The severity of daytime sleepiness was quantified subjectively using the Epworth Sleepiness Scale 
(ESS) and the Stanford Sleepiness Scale (SSS), and objectively using the Multiple Sleep Latency Test (MSLT). All subjects underwent 
polysomnography (PSG) on the two consecutive nights. The data from the second night was analysed. The slow wave activity 
(SWA, 1–4  Hz) was calculated for the three consecutive sleep cycles, and topographic delta power maps were plotted. In contrast 
to narcoleptics, psychiatric hypersomniacs had undisturbed nocturnal sleep, high sleep efficiency, normal non-rapid eye movement 
(NREM) and rapid eye movement (REM) sleep proportions, normal REM latency and sleep latencies on MSLT and PSG. The subjective 
and objective sleepiness was significantly higher in narcolepsy group than in psychiatric hypersomnia group. In all the study groups SWA 
was the most prominent in frontal areas, while the greatest between-group differences were found in the central areas. There were 
significant differences between the groups in SWA in the second NREM episode. The highest SWA was observed in the hypersomnia 
group, while the lowest in the narcolepsy group. Psychiatric hypersomniacs and controls did not differ in the SWA exponential decline 
over consecutive NREM episodes, whereas narcoleptics exhibited a steeper dissipation of sleep pressure from the first to the second 
NREM episode. In conclusion, narcolepsy type1 and hypersomnia associated with psychiatric disorder differ in the SWA dynamics. 
Narcoleptics presented with the altered dynamics of sleep homeostasis, whereas psychiatric hypersomniacs showed normal nocturnal 
sleep and normal sleep homeostasis.
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INTRODUCTION
According to the third revision of the International 
Classification of Sleep Disorders (ICSD‑3), narcolepsy 
type 1 (N1) and hypersomnia associated with a psychiatric 
disorder (HPD) belong to the group of Central Disorders 
of Hypersomnolence. They are characterized by excessive 
daytime sleepiness (EDS) that is not caused by a disturbed 
sleep, abnormalities of respiration during sleep or 
misaligned circadian rhythms (American Academy of 
Sleep Medicine 2014). EDS occurs in 5–15% of the general 
population (Partinen and Hublin 2011).
Narcolepsy type 1 (narcolepsy with cataplexy, NC, 
according to ICSD‑2) (American Academy of Sleep 
Medicine 2005) is a homogenous condition caused by 
a deficiency of hypothalamic hypocretin transmission. 
The disorder is characterized by EDS, signs of rapid eye 
movement (REM) sleep dissociation, like cataplexy, sleep 
paralysis, hypnagogic hallucinations and fragmented 
nocturnal sleep (American Academy of Sleep Medicine 
2014). Total sleep time over 24 hour period in narcoleptics 
is normal but its distribution is altered. The patients 
exhibit more daytime sleep and more wakefulness 
during sleep than controls (Broughton et al. 1988). It is 
postulated that the severe hypocretin deficiency results 
in the destabilization of hypothalamic control of sleep 
and wakefulness and causes sleep‑wake transitions 
instabilities (Saper et al. 2001, Sorensen et al. 2013).
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On the contrary, hypersomnia associated with 
a psychiatric disorder is a heterogenous condition with 
EDS, excessive nocturnal sleep, or excessive napping. 
Associated psychiatric disorders include mood disorders, 
conversion or somatoform disorders, and other mental 
disorders. There is no concordance between subjective 
and objective sleepiness. The mechanisms through 
which the sufferers express their psychiatric symptoms 
as excessive sleepiness is still unknown (American 
Academy of Sleep Medicine 2014). Hypersomnia is highly 
prevalent in various mood disorders and is associated 
with increased risk of depressive relapse and suicide. 
Hypersomnia is often treatment resistant. Despite its 
significant impact on natural history of mood disorders, 
the origins, clinical manifestations, course and sequelae 
of hypersomnia associated with a psychiatric disorder 
are poorly understood (Kaplan and Harvey 2009, Plante 
2015). Polysomnography (PSG) studies in depression 
show disturbances of sleep continuity, reduction of slow 
wave sleep (SWS) and disinhibition of REM sleep (Kupfer 
and Foster 1972, Benca et al. 1992, Riemann et al. 2001). 
According to the Two‑Process Model of Sleep 
Regulation, the sleep propensity is jointly determined by 
a homeostatic and a circadian process. The homeostatic 
process (Process S) increases gradually during 
wakefulness, which reflects an increasing sleepiness, 
and declines exponentially during sleep. A reliable 
electroencephalography (EEG) marker of Process S is 
slow wave activity (SWA, 1–4 Hz), an indicator of sleep 
homeostasis and sleep intensity (Borbély and Tobler 
2011). In depression, the build‑up of process S is deficient, 
which results in SWS reductions during sleep and shorter 
REM sleep latency. After sleep deprivation the process S 
is restored to the normal level, which causes an instant 
but short antidepressant effect (Borbély 1987, Borbély 
and Wirz‑Justice 1982). Although sleep in depression has 
been widely studied there is still limited data on sleep in 
psychiatric hypersomnia. Dolenc and others (1996) found 
the reduction of SWS in patients with dysthymia and 
hypersomnia. Plante and colleagues (2012) demonstrated 
the significant reduction of SWA in patients with 
major depressive disorder (MDD) and hypersomnia. 
It suggests the insufficient build‑up of the process S 
during wakefulness in psychiatric hypersomnia. Similar 
mechanism is postulated in idiopathic hypersomnia 
(Sforza et al. 2000).
In narcolepsy, PSG studies consistently show a disrupted 
night sleep with frequent brief awakenings, arousals and 
an increased amount of stage 1 sleep (Overeem et al. 2001, 
Roth et al. 2013, American Academy of Sleep Medicine 
2014). The destabilization of hypothalamic control of sleep 
and wakefulness results in frequent, undesired sleep‑wake 
state transitions (Saper et al. 2001, Sorensen et al. 2013). 
Khatami and others (2007) found that narcoleptic subjects 
exhibited a steeper declining trend of SWA from the first to 
the second sleep episode in comparison to controls, which 
results from an insufficient non‑rapid eye movement 
(NREM) intensity.
The differential diagnosis of hypersomnias is 
a challenging task because the diagnostic criteria overlap 
(Vgontzas et al. 2000, American Academy of Sleep Medicine 
2014). There are no definite tests to confirm HPD and a broad 
differential diagnosis is needed to rule out other causes 
of sleepiness. There are limited studies using objective 
measures of sleep propensity in psychiatric hypersomnia. 
EDS in mood disorders is rather a subjective complaint than 
an objective finding. Besides, depressive symptoms are 
frequently noted in central disorders of hypersomnolence, 
for example in narcolepsy (Dauvilliers et al. 2013), which 
makes the differential diagnosis of various hypersomnias 
more difficult.
Therefore, we aimed to evaluate electrophysiological 
parameters of central disorders of hypersomnolence. 
To the best of our knowledge, there are no studies on 
sleep EEG brain mapping in patients with hypersomnia 
associated with a psychiatric disorder compared to 
patients meeting criteria of narcolepsy type 1 and healthy 
controls. Furthermore, we evaluated sleep parameters, 
daytime sleepiness, subjective difficulties with night sleep, 
depressive feelings and psychosocial impact in the two 
groups of patients.
METHODS
Participants
The study was performed in twenty nine outpatients 
meeting ICSD‑3 (American Academy of Sleep Medicine 
2014) criteria for central disorder of hypersomnolence, 
15 subjects with narcolepsy type 1 (narcolepsy with 
cataplexy, 6 men and 9 women, N1) and 14 with 
hypersomnia associated with a psychiatric disorder (6 men 
and 8 women, HPD), recruited from Sleep Disorders Clinic, 
Medical University of Warsaw. Psychiatric diagnoses were 
established according to the International Classification 
of Diseases, 10th Edition (ICD‑10) criteria (World Health 
Organization 1993). Exclusion criteria included: somatic 
disorders, misusing substances or drugs, psychotic or 
dementia disorders, other sleep disturbances causing 
sleepiness as breathing‑related sleep disorders or 
insufficient sleep syndrome.
The control group consisted of 15 healthy age‑ and 
sex‑matched volunteers, recruited from the employees of 
the Nowowiejski Hospital in Warsaw and the Institute of 
Cardiology in Warsaw (C). 
Both healthy volunteers and patients were required 
to be free of any prescription or nonprescription drugs 
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for at least 2 weeks prior to the study. Sleep habits were 
confirmed by sleep diaries. All subjects gave informed 
consent before participating. The study was approved by 
the University Bioethics Committee. 
Procedure
Prior to entering the study, each subject underwent 
psychometric assessment including the Beck Depression 
Inventory (BDI, Beck et al. 1961). The disruption of night 
sleep was quantified by means of 8‑item version of the 
Athens Insomnia Scale (AIS, Soldatos et al. 2000, 2003, 
Fornal et al. 2011), the severity of daytime sleepiness was 
assessed subjectively using the Epworth Sleepiness Scale 
(ESS, Johns 1991) and the Stanford Sleepiness Scale (SSS, 
Hoddes et al. 1973), and objectively using the Multiple 
Sleep Latency Test (MSLT, Carskadon 1986).
EEG data and visual scoring
All participants were studied on two consecutive nights 
with laboratory‑based PSG. The first adaptative night was 
used to rule out sleep apnea, periodic limb movements 
and other sleep disorders. On the second night, EEG signal 
was recorded from 23 derivations following an extended 
version of the international 10–20 system (with additional 
electrodes at Fpz and Oz) versus reference electrode 
positioned between Fz and Cz. The impedance of the 
electrodes was kept below 10 kΩ. The signals were sampled 
at 128 Hz and filtered between 0.15 and 30 Hz. Sleep stages 
were visually scored according to the Rechtschaffen 
and Kales criteria (1968), in 20 s segments, from C3‑A2 
derivation. Directly after the second night of PSG, the 
consecutive five sessions of routine diagnostic MSLT were 
conducted (Carskadon 1986).
EEG data and spectral analysis
EEG data from the second nights of PSG recordings were 
subjected to spectral analyses. First, the power spectra were 
calculated using a fast Fourier transform algorithm (FFT) 
in 4 seconds segments (Hamming widow) for the whole 
sleep. FFT was performed for frequencies between 1 and 
35 Hz (data from C3‑A2 derivation). The data were plotted 
to make individual EEG‑chronospectrograms. Second, the 
EEG‑chronospectrograms were compared to individual 
hypnograms and the three consecutive NREM‑REM sleep 
cycles were marked according to Feinberg and Floyd 
criteria (1979). The peak values of SWA were visually 
detected and matched with hypnograms to determine the 
last 240 seconds of artefact‑free EEG recordings of SWS 
(stage 3 or 4) for the three consecutive sleep cycles in every 
subject. The EEG was converted to an average reference, 
and spectral analysis was performed for 240 s of the peak 
value of SWA in the three consecutive sleep NREMs for 
21 channels. Maps of absolute delta power (1–4 Hz) were 
plotted for the sleep cycles.
We used REMbrandt®7.2 Sleep Diagnostic Software, The 
Source Advanced Analysis software package (ASA 4; ANT 
Software BV) and topoplot function of EEGLAB software for 
the quantitative analysis of the EEG.
Statistical analysis
Normal distribution in the groups was checked with 
Kolmogorov‑Smirnov test. We used one‑way ANOVA test 
and post‑hoc Duncan test for comparisons between groups 
for variables with normal distribution. For variables 
with non‑normal distribution we used nonparametric 
Kruskal‑Wallis test, and the t‑test for comparisons between 
the two groups. 
Comparisons between the 3 groups for the 3 consecutive 
sleep cycles were performed using one‑way ANOVA test 
and post‑hoc Duncan test. Changes in the value of power 
in subsequent sleep cycles and the percentage of power 
decrease were analyzed for two derivations (Fz, Cz) using 
two‑way analysis of variance for repeated measures 
(rANOVA, groups * sleep cycles). 
All statistical calculations were performed using 
program STATISTICA 12.0 (Stat Soft, Krakow, Poland).
The results of the study are presented as arithmetic 
mean and standard error (±SE). We considered p<0.05 as 
statistically significant.
RESULTS
Demographic and clinical characteristics 
There were no significant differences between groups 
in mean age (N1 – mean age 34.4±2.97, range 17–53 years; 
HPD – mean age 27.7±2.39, range 21–56 years; C – mean 
age 32.2±2.42, range 22–51 years; F2,41=1.7, p=0.2). 
Narcoleptics were less educated than HPD and C. Their 
education was shorter (10.87 years±0.93) comparing to 
HPD (13.86±0.8) and C (15.67 ±0.7, N1 vs. C p<0.001, N1 vs. 
HPD p<0.05; post‑hoc Duncan test). 
4 of 15 patients with N1 and 3 of 14 patients with 
HPD were unemployed. Five narcoleptics complained 
about job loss because of daytime sleepiness. 9 of 15 
narcoleptics and 2 of 14 hypersomniacs claimed that 
they had sleep‑related accidents. In 5 narcoleptics and 
in 1 hypersomniac the accident occurred during driving. 
In 4 of 15 narcoleptics and 1 of 14 hypersomniac an 
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accident occurred while operating house equipment, 
and in 5 of 15 narcoleptics an accident occurred at work. 
Three narcoleptics had several accidents under various 
circumstances.
All the HPD patients had ICD‑10 (World Health 
Organization 1993) psychiatric diagnosis: 5 subjects were 
diagnosed with dysthymic disorder, 1 subject with major 
depressive disorder, single episode, in partial remission, 
3 subject with mixed anxiety and depressive disorder, 
6 subjects with somatoform disorders and 1 subjects with 
dissociative disorder. 12 patients had one and 2 patients 
obtained two psychiatric diagnoses. We also found that 
4 of 15 narcoleptics had additional psychiatric diagnosis: 
3 subjects were diagnosed with major depressive disorder 
and 1 subject with adjustment disorder.
Psychometric tests
The BDI results differed significantly between 
the groups (F2.41=10.51, p<0.001), N1 and HPD subjects 
obtained higher scores than C subjects (N1 – 15±2.29 vs. 
C – 2.47±0.8, p<0.001, HPD – 12.14±2.65 vs. C – 2.47±0.8, 
p<0.01, post‑hoc Duncan test). 
15/15 of N1 and 12/14 of HPD subjects filled in 
the AIS. They complained of difficulties with night 
sleep and their AIS scores were higher than those of 
healthy controls (F2,39=10.19, p<0.001, N1 – 9.6±1.22 vs. 
C – 3.67±0.44, p<0.01, HPD – 10.5±1.6 vs. C – 3.67±0.44, 
p<0.001, post‑hoc Duncan test).
Analyses of daytime sleepiness between the N1 and 
the HPD groups showed a significant difference. The N1 
group scored significantly higher than the HPD group on 
the ESS (20.06±0.93 vs. 14.92±0.7, t=4.32, p<0.001) and on 
the SSS (5.46±0.34 vs. 3.57±0.34, t=3.94, p<0.001).
PSG parameters
The comparison of PSG parameters demonstrated 
significant differences between narcolepsy and the two 
remaining groups (Table I). N1 exhibited significantly 
shorter sleep latency, more stage 1 sleep, more wake 
during sleep, less stage 2 and stage 3+4 sleep comparing 
to HPD and C. Moreover, N1 showed a significantly 
shorter REM sleep latency than the other groups, 
whereas REM sleep duration and percentage did not 
differ.
The mean sleep latency measured using MSLT 
was significantly shorter in N1 than in HPD and C 
(F2,41=91.37, p<0.001; N1 – 2.86±0.45, HPD – 12.14±0.72, 
C – 14.49±0.75; N1 vs. C p<0.001, N1 vs. HPD p<0.001, 
HPD vs. C p<0.05, post‑hoc Duncan test). N1 showed 
significantly more Sleep Onset REM Periods (SOREMPs) 
than HPD and C subjects (H2.41=39.28, p<0.001; 
N1 – 3±0.28, HPD – 0.07±0.07, C – 0; N1 vs. C p<0.001, 
N1 vs. HPD p<0.001, Kruskal‑Wallis test).
EEG spectral analysis
In all the groups the predominance of EEG delta 
activity in the three NREM sleep episodes was observed 
in frontal areas. The delta power decreased across the 
Table I. Polysomnographic parameters of night sleep in narcolepsy group – N1, hypersomnia group – HPD, and control subjects – C [ANOVA df 2,41 – (F), 
Kruskal-Wallis test df 2,41 – (H)]. Means ±Standard Errors (SE) are shown. * p<0.05 for N1 vs. HPD, # p<0.05 for N1 vs. C (post-hoc)
Group
Sleep parameters
N1 (n=15)
Mean ±SE
HPD (n=14)
Mean ±SE
C (n=15)
Mean ±SE
F/H, p
Sleep latency (min) 2.56±0.46*# 15.72±3.9 16.78±3.12
F=7.87
p<0.01
Total sleep time (min) 401.21±17.03 418.99±14.63 385.74±10.16 NS
Sleep efficiency (%) 88.26±2.69 94.24±2.42 94.2±1.35 NS
REM sleep latency (min) 21.75±11.42*# 75.96±8.57 86.51±8.79
H=17.39
p<0.001
stage 1 of NREM sleep (%) 18.52±4.06*# 4.69±1.05 5.04±1.2
F=9.54
p<0.001
stage 2 of NREM sleep (%) 39.19±2.13*# 50.72±2.06 50.52±1.14
F=13.25
p<0.001
stages 3+4 of NREM sleep (%) 15.69±1.54*# 19.44±1.33 21.43±0.58
F=5.87
p<0.05
REM sleep (%) 26.55±2.58 25.14±1.36 22.79±1.17 NS
Wake after sleep onset (%) 13.17±3.93*# 5.86±3.71 3.15±1.63
H=9.31
p<0.05
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Fig. 1. (A). The topographic distribution of delta power in consecutive NREM episodes (1, 2, 3) in control subjects (C, n=15), Narcolepsy type 1 (N1, n=15) and 
Hypersomnia associated with a psychiatric disorder (HPD, n=14). The last column shows the F values for C-N1-HPD comparison by one-way ANOVA; p<0.05 
for F equal or more than 3.32. Significant between group differences were found in the second NREM episode in 18 out of 21 EEG derivations (detailed 
data is shown in B). (B). The mean values of absolute delta power from 21 EEG derivations in the second NREM episode in control subjects (C, n=15, green 
bars), Narcolepsy type 1 (N1, n=15, blue bars) and Hypersomnia associated with a psychiatric disorder (HPD, n=14, red bars). The comparison of SWA in 
the three groups (ANOVA, post-hoc Duncan) from EEG derivations. * p<0.05 (N1 vs. HPD), # p<0.05 (N1 vs. C).
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three consecutive NREMs in the HPD and C groups. In 
the N1 group the delta power decreased from the first to 
the second episode and then increased from the second 
to the third episode in almost all EEG derivations (18 of 
21). The topographic distribution of SWA and the maps 
of between groups differences in the three consecutive 
NREM episodes are depicted on Fig. 1A. 
There were significant differences between the 
groups in delta power in the second NREM episode. The 
highest level of SWA was observed in the HPD group, the 
intermediate level in controls and the lowest in the N1 
group. The greatest differences were present in the central 
areas (Fig. 1B).
The predominance of SWA was observed in the three 
groups in frontal areas and the greatest between group 
differences were seen in central areas. Thus the Fz 
and Cz leads were selected for the comparison of SWA 
dissipation over three consecutive NREM episodes. 
Two‑way rANOVA revealed significant difference in 
the relative delta power change in time between groups 
for Cz derivation (groups N1, HPD, C × sleep episode 
2–3, F2,40=3.33, p<0.05) and for Fz derivation (groups N1, 
HPD, C × sleep episode 2–3, F2,40=3.54, p<0.05). Post‑hoc 
analysis showed that N1 had significantly lower relative 
SWA than HPD for Cz and Fz derivations in the second 
NREM episode. N1 had significantly lower relative SWA 
Fig.  2. The percentage change of slow-wave activity (SWA) across three consecutive NREM sleep episodes for Cz and Fz derivations in three groups: 
narcolepsy type 1 (N1, n=15, black lines, black diamonds), hypersomnia associated with psychiatric disorder (HPD, n=14, grey lines, grey squares) and 
control subjects (C, n=15, dashed lines, black rectangles). SWA values are showed as a relative to the SWA value of the first NREM episode (100%). (A) shows 
the averaged group values of SWA ±SE in the three NREM episodes. * p<0.05 for N1 vs. HPD, # p<0.05 for N1 vs. C (ANOVA, post-hoc Duncan). (B) shows the 
individual values of SWA in the time after sleep onset. The curves represent the trend lines for SWA change.
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than C for Fz derivation in the second NREM episode. In 
the N1 group in the Cz derivation there was a decrease 
of SWA followed by an increase of SWA, while in the Fz 
derivation SWA did not change significantly between 
the second and the third NREM episodes. HPD and C did 
not differ in the SWA exponential decline over NREM 
episodes, whereas N1 exhibited a steeper sleep pressure 
dissipation from the first to the second NREM episode 
than HPD and C (Fig. 2).
DISCUSSION
A new finding of the study is that psychiatric 
hypersomniacs and narcoleptics differ in the SWA 
exponential decline over NREM sleep episodes.
Our study confirmed a profound psychosocial impact 
of narcolepsy. Narcoleptic patients were less educated 
than hypersomniacs and controls. One third of the 
N1 group lost a job because of EDS, and one third had 
a sleep‑related automobile accident. This is in line with 
previous studies showing lower quality of life, higher 
frequency rates of automobile accidents and decreased 
simulated driving performance in narcolepsy (Broughton 
et al. 1981, George et al. 1996, Findley et al. 1999).
BDI scores indicated a moderate depression in the 
N1 and the HPD groups according to the validation of 
the Polish version of the inventory (Parnowski and 
Jernajczyk 1977). Self‑reported depressive symptoms in 
patients with sleep disorders were also reported in the 
previous study, with the mean BDI score for narcoleptics 
of 10 or more (Mosko et al. 1989, Daniels et al. 2001, 
Vandeputte and Weerd 2003, Dauvilliers et al. 2009). 
In our study, BDI scores in the HPD group were lower 
than in the N1 group, and lower than in nonorganic 
hypersomnia in the study by Kofmel and others (2014). In 
our HPD group only 6 of 14 subjects met mood disorders 
criteria. The frequency of low mood disorders in our 
HPD group is in line with HPD differentiation into two 
subtypes i.e., mood disorders and a conversion disorder 
or somatic symptom disorder, according to ICSD‑3 
(American Academy of Sleep Medicine 2014).
The subjective and objective sleepiness
In our study, narcolepsy and hypersomnia subjects 
scored higher in the AIS than controls, which reflects 
subjective complaints on night sleep. Narcoleptics 
typically report disruption of nocturnal sleep such as 
an inability to maintain sleep (Aldrich 1992, Overeem 
et al. 2001, Dauvilliers et al. 2007, American Academy of 
Sleep Medicine 2014). The N1 group showed an elevated 
AIS score, which was coherent with PSG results and 
reflected the disrupted night sleep. In contrast, the HPD 
group complained about the poor quality of sleep despite 
normal PSG results.
The severity of subjective and objective daytime 
sleepiness was significantly higher in the N1 group 
than in the HPD group. The N1 group obtained higher 
scores in the sleepiness scales than the HPD group. The 
N1 group had severe subjective sleepiness according 
to Mitler and colleagues (2000), which was in line with 
objective measures in our study. Namely, the N1 group 
showed significantly shorter night sleep latency, REM 
latency, mean sleep latency in MSLT, and more SOREMS 
in MSLT in comparison to the HPD group and controls. 
The results confirm severe EDS in the N1 group, which is 
consistent with previous study by Dauvilliers and others 
(2001) and ICSD‑3 (American Academy of Sleep Medicine 
2014). In contrast to severe subjective and objective 
sleepiness in the N1 group, psychiatric hypersomniacs 
exhibited a moderate subjective sleepiness (Mitler et al. 
2000) with no indicators of objective sleepiness, the mean 
sleep latency in MSLT in the HPD group was within the 
reference range for healthy. The discrepancy between 
objective and subjective findings is typical for HPD 
(American Academy of Sleep Medicine 2014). It is worth 
noting that although the MSLT is a widely used tool to 
measure the sleep propensity for diagnostic purposes 
it has several limitations. For example, the mean sleep 
latency of less than 8 minutes is a cut‑off to define 
a pathological sleepiness (American Academy of Sleep 
Medicine 2014), while the meta‑analysis by Plante and 
colleagues (2017) showed that the sleep propensity in 
patients with psychiatric hypersomnolence is similar to 
normal values, with only 25% of patients having the mean 
sleep latency below 8 minutes. It is unknown whether 
patients with HPD are essentially sleepy, or if they suffer 
from the lack of energy. Moreover, the differentiation 
between EDS and fatigue in HPD is particularly difficult 
and it is unknown to what extent those two symptoms 
overlap (Ohayon 2008).
The night sleep parameters
Comparison of sleep parameters demonstrated worse 
sleep quality in the N1 group than in the HPD group and 
controls. The N1 group presented with significantly more 
stage 1 sleep, less stage 2, 3+4 sleep and more wake during 
sleep when compared with the HPD group and controls. 
This indicates a decrease of slow‑wave sleep and an 
increase of wakefulness and light sleep in our N1 group. 
Our results are in line with previous studies on disturbed 
nocturnal sleep in narcolepsy (Overeem et al. 2001, Roth et 
al. 2013, American Academy of Sleep Medicine 2014). The 
HPD group had normal, undisturbed nocturnal sleep, high 
6_948_Walacik-Ufnal_v5.indd   153 23/06/17   19:11
154 E. Walacik-Ufnal et al. Acta Neurobiol Exp 2017, 77: 147–156
sleep efficiency, normal NREM and REM sleep proportions 
in comparison to controls. There are only a few PSG 
studies in HPD. Similarly to our results, Nofzinger and 
others (1991) didn’t find sleep disturbances in patients 
with hypersomnia in bipolar depression. Billiard and 
colleagues (1994) found that the main pathology among 
subjects affected with hypersomnia associated with 
mood disorders was anergia facilitating or mimicking 
sleep. On the contrary, Dolenc and others (1996) found 
the abnormal macrostructure of sleep in 12 patients with 
dysthymia and hypersomnia. Similarly, Vgontzas and 
colleagues (2000) showed a disrupted nocturnal sleep in 
patients with psychiatric hypersomnia.
SWA
The topographic maps of NREMs revealed the highest 
SWA in frontal regions in the three studied groups. The 
predominance of EEG power in frontal regions in NREMs 
is well documented in literature (Tinguely et al. 2006).
The lowest SWA was observed in the N1 group, the 
intermediate in controls and the highest in the HPD 
group (see Fig. 1), however the difference was significant 
only in the second NREM episode.
Narcoleptics had the lowest SWA in spite of the highest 
level of EDS measured objectively and subjectively. 
Similarly, Pizza and others (2013) and Guilleminault 
and others (1998) found lower SWA in narcoleptics than 
in controls, suggesting the impairment of process S in 
narcolepsy. Insufficient sleep pressure may compromise 
consolidation and maintenance of sleep. The lower level 
of SWA and the insufficient NREM sleep intensity in 
the N1 group are coherent with the sleep disruption in 
PSG. Moreover, the N1 group presented with different 
SWA dynamics than HPD group and control subjects. 
The N1 group showed the steeper decline of SWA from 
the first to the second NREM episode. Similar findings 
were reported by Khatami and colleagues (2007) who 
found the steeper decay of SWA in NC, which reflected 
the inability to consolidate sleep and the insufficient 
NREM sleep intensity. After sleep deprivation SWA was 
increased and sleep fragmentation was postponed in NC, 
which indicates the preserved homeostatic regulation in 
NC (Khatami et al. 2008).
In our study the HPD group had the highest SWA. 
Significant differences between the three groups 
occurred in the second NREM episode (see Fig. 1B). 
The HPD group didn’t show the sleep changes typical 
for depression. This is coherent with a moderate 
level of depressive feelings in the group. There are 
contradictory reports with regard to changes in sleep in 
depression. Peterson and Benca (2011) didn’t find typical 
depression sleep changes in bipolar depression, atypical 
depression and in young patients with depression. PSG 
results and high SWA in our HPD group resemble sleep 
after deprivation, except of normal sleep latencies and 
normal SWS sleep proportions. Schwartz and others 
(2001) found higher SWA in NREMs and sleep profiles 
resembling sleep after deprivation in patients with 
seasonal affective disorder. There is some evidence 
of the depressogenic effect of NREM sleep in major 
depression (Beersma and van den Hoofdakker 1992). 
On the other hand, there is a hypothesis of depression 
that attributes the sleep changes in depression to the 
deficiency of Process S (Borbély 1987). The reduction 
of SWA in MDD and hypersomnia was demonstrated by 
Plante and others (2012) and in idiopathic hypersomnia 
by Sforza and colleagues (2000). It is assumed that the 
Process S–deficiency plays a role in the pathophysiology 
of hypersomnia. Our study shows that sleep pressure 
discharging in the HPD group and in controls was the 
same. It indicates the high sleep pressure, high sleep 
intensity and normal sleep homeostasis in HPD. Higher 
SWA is an objective finding that may confirm sleepiness 
in our HPD group. Further research is needed to find the 
mechanism through which the hypersomniacs express 
their psychiatric symptoms into excessive sleepiness.
To summarize, we compared PSG data and power 
spectra of hypersomnia associated with a psychiatric 
disorder and narcolepsy type 1. We found discrepancies 
between objective and subjective findings in the HPD 
group. Despite complaints of EDS, HPD subjects had 
normal sleep latencies in MSLT and in PSG, undisturbed 
nocturnal sleep and high sleep efficiency. In contrast, 
the N1 group presented with disturbed nocturnal sleep 
with a decrease of slow‑wave sleep and an increase of 
wakefulness and light sleep. The HPD and the N1 groups 
differed in the SWA exponential decline over NREM 
episodes. The N1 group exhibited a steeper dissipation of 
sleep pressure from the first to the second NREM episode 
than the HPD group and controls. The discharging of 
sleep pressure in the HPD group and in controls was 
the same. The study indicates low sleep intensity and 
altered homeostatic sleep regulation in N1. In contrast, 
the HPD group exhibited normal sleep homeostasis, high 
sleep pressure and high sleep intensity. Additionally, we 
confirmed a profound psychosocial impact of narcolepsy. 
We also found elevated subjective measures of disturbed 
sleep and elevated measures of depression in the HPD and 
the N1 groups.
CONCLUSION
Our study shows that narcolepsy type 1 and hypersomnia 
associated with a psychiatric disorder differs in the SWA 
dynamics. 
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